IPO registrations (S-1, F-1) · Registrants

ALBANY MOLECULAR RESEARCH INC

SEC CIK
1065087 · filings on EDGAR ↗
Registration
Form S-1, first filed 1998-07-09, last 1999-02-02; 1 initial registration, 5 amendments
Outcome
Final prospectus filed 1999-02-05
Industry (SIC)
Services-Commercial Physical & Biological Research 8731
Incorporated in
DE
Business address
21 CORPORATE CIRCLE, P O BOX 15098, Albany, NY 12203-5154
EIN
14-1742717
EDGAR entity type
operating
Insiders and CEO pay
ALBANY MOLECULAR RESEARCH INC on the corporate pages

Offering terms

Proposed price range
$17.00–$19.00 per share (S-1/A filed 1999-02-02)
Final price
$2.47 per share, below the range (424B4 filed 1999-02-05, an initial public offering)
Shares sold
2,500,000
Gross proceeds
$6,175,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol AMRI
Lead underwriters
ING; Hambrecht & Quist (742,500 shares)
Syndicate
Robertson Stephens (70,000); Bear Stearns (70,000); BT Alex. Brown (70,000); Oppenheimer (70,000); EVEREN Securities, Inc (70,000); Lehman Brothers (70,000); Morgan Stanley (70,000); Montgomery Securities (70,000); Cowen (70,000); UBS (70,000); William Blair (35,000); RBC Capital Markets (35,000); Dominick & Dominick LLC (35,000); First Albany Corporation (35,000); Interstate/Johnson Lane Corporation (35,000); C.L. King & Associates (35,000); Pacific Growth Equities, Inc (35,000); Pennsylvania Merchant Group Ltd (35,000); Piper Sandler (35,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 9

FiledFormWhat it isName as filedEDGAR
1998-07-09S-1S-1 (registration)ALBANY MOLECULAR RESEARCH INC0000927016-98-002632 ↗
1998-07-15S-1/AS-1/A (amendment)ALBANY MOLECULAR RESEARCH INC0000927016-98-002666 ↗
1998-08-14S-1/AS-1/A (amendment)ALBANY MOLECULAR RESEARCH INC0000927016-98-003147 ↗
1998-12-08S-1/AS-1/A (amendment)ALBANY MOLECULAR RESEARCH INC0000927016-98-004196 ↗
1999-01-07S-1/AS-1/A (amendment)ALBANY MOLECULAR RESEARCH INC0000927016-99-000023 ↗
1999-02-02S-1/AS-1/A (amendment)ALBANY MOLECULAR RESEARCH INC0000927016-99-000260 ↗
1999-02-05S-1MEFS-1MEF (added securities)ALBANY MOLECULAR RESEARCH INC0000927016-99-000309 ↗
1999-02-05424B4424B4 (final prospectus)ALBANY MOLECULAR RESEARCH INC0000927016-99-000310 ↗
2000-10-06424B4424B4 (final prospectus)ALBANY MOLECULAR RESEARCH INC0000912057-00-044092 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
1999-02-02S-1/Aregistration statement$17.00–$19.002,200,000-Nasdaq AMRI2from the submission text; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 2document ↗
1999-02-05424B4final prospectus$2.472,500,000$6,175,000Nasdaq AMRI21from the submission text; price line, shares headline, proceeds computed, underwriting table 20, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ANDERSON PAUL SDirector102006–2011
KUHLA DONALD EDirector; Director,OfficerExecutive Vice President72006–2008
OCONNOR KEVINDirector262006–2017
ROTH ARTHUR JDirector242006–2017
TARTAGLIA ANTHONY PDirector92006–2009
Frost Mark TOfficerChief Financial Officer122006–2012person page Fuzzy
Shultis Kenton LOfficerVP and GM, Organichem12006
TROVA MICHAEL POfficerSr. VP, Chemistry12006
HAYDU FRANKDirector12006
RYAN UNA SDirector242006–2017person page Fuzzy
D AMBRA CONSTANCE MTenPercentOwner322006–2016
D AMBRA THOMAS EDirector; Director,Officer,TenPercentOwner; DirectorOtherChairman, Board of Directors; Chairman, CEO & President512006–2017
Jordan Veronica GHDirector202006–2016
Evans Johnathan DOfficerVP Pharma Dev & Manu32007
JENNINGS WILLIAM STEVENOfficerSenior Vice President32008–2010
Hagen Steven ROfficerSr VP Pharmaceutical Dev & Mfg; SVP Manufacturing & Pharmaceut; SVP Pharmaceutical Dev & Mfg; VP Pharmaceutical Dev & Mfg892008–2017
LEUNG GABRIELDirector102010–2015
HENDERSON LORI MOfficerSVP, Secretary & Gen Counsel; SVP, Secretary & Gen. Counsel; VP, general counsel; VP, Secretary & Gen. Counsel372011–2017
Sargent Bruce JOfficerSr VP, Drug Discovery152011–2013
CABLE STUART MTenPercentOwner282011–2015
Marth William SDirector; Director,OfficerPresident and CEO302012–2017
Nolan Michael MOfficerCFO; SVP, CFO and Treasurer; VP, CFO and Treasurer112012–2015
DAmbra GeoffreyTenPercentOwner12013
THOMAS DAMBRA SLAT TRUSTTenPercentOwner12013
Luther Michael AOfficerSenior VP, Discovery Services; Senior VP. Discovery Services42013–2015
Svokos GeorgeOfficerChief Commercial Officer; Chief Operating Officer; Sr. VP Sales & GM of API; SVP Sales & GM of API222014–2017
Ladin Felicia IOfficerCFO; SVP & Treasurer; SVP, Treasurer & CFO112015–2017
Gutierrez Fuentes Luis GerardoDirector52015–2017
D'Ambra DavidTenPercentOwner22015–2016
MADDALUNA ANTHONY JDirector62016–2017
Deming David HDirector42016–2017
HAGEN KENNETH PAULDirector42016–2017
NAPOLITANO FERNANDODirector32016–2017
Clessidra S.G.R. S.p.A.Other12016
Lauro Cinquantasette S.p.A.Director,TenPercentOwner12016
Lauro Quarantotto S.p.A.Other12016
Mandarin Capital Management Secondary SAOther12016
Mandarin Capital Partners Secondary SCA SICAROther12016
BOYER MILTONOfficerSVP, Drug Product Manufacturin; SVP Drug Product Manufacturing72016–2017
CONWAY CHRISTOPHER M.OfficerSVP, Discovery and Development62016–2017
FINE MARGALITOfficerExecutive Vice President, API42016–2017

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorCURIA GLOBAL, INC.NYForm 5500 (employee benefit plans)EIN (EXACT)
Patent assigneeALBANY MOLECULAR RESEARCH, INC.NYPatents (USPTO)name and state
SEC filerALBANY MOLECULAR RESEARCH INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerAlbany Molecular Research, Inc.NYTrademarks (USPTO)name and state
Form 5500 plan sponsorCURIA GLOBAL INC.EIN (EXACT)
Person pageMark T FrostPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer)
Person pageUna S RyanPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Services-Commercial Physical & Biological Research, NY first:

More with this interest.

In other datasets, the same topic (Medical research) in NY:

Interests: Services-Commercial Physical & Biological Research · Medical research